EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Beyond Inhibition: Rebalancing the Hsp90 Chaperone Network as a Therapeutic Strategy for Alzheimer’s Disease

Zhikang Tang, Haiyu Xie, Yongxing Xu, Zhenhong Zhou, Feng Lu, Qiaozhen Wu, Weidong Liang iD, Maolin Zhong, Shihong Li iD

Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-15

DOI: 10.2147/dddt.s602287 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Zhikang Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China. Hauptthemen laut MEDLINE: HSP90 Heat-Shock Proteins, Alzheimer Disease, Molecular Chaperones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HSP90 Heat-Shock ProteinsAlzheimer DiseaseMolecular ChaperonesHumansAnimalstau ProteinsAmyloid beta-Peptides

Stichwörter der Autor:innen

Alzheimer’s diseaseheat shock protein 90molecular chaperonesproteostasistauopathy

Substanzen

HSP90 Heat-Shock Proteinstau ProteinsMolecular ChaperonesAmyloid beta-Peptides

Autor:innen und Institutionen

  • The First Clinical Medical College of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.
  • Department of Anesthesiology, Ganzhou Key Laboratory of Anesthesiology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.

ORCID-Profile: Weidong Liang, Shihong Li

Zitieren

APA

Tang, Z., Xie, H., Xu, Y., Zhou, Z., Lu, F., Wu, Q., Liang, W., Zhong, M., & Li, S. (2026). Beyond Inhibition: Rebalancing the Hsp90 Chaperone Network as a Therapeutic Strategy for Alzheimer’s Disease. Drug Design, Development and Therapy, Volume 20, 1-15. https://doi.org/10.2147/dddt.s602287

Vancouver

Tang Z, Xie H, Xu Y, Zhou Z, Lu F, Wu Q, et al. Beyond Inhibition: Rebalancing the Hsp90 Chaperone Network as a Therapeutic Strategy for Alzheimer’s Disease. Drug Design, Development and Therapy. 2026;Volume 20:1-15. doi:10.2147/dddt.s602287

BibTeX
@article{Tang2026,
  author = {Tang, Zhikang and Xie, Haiyu and Xu, Yongxing and Zhou, Zhenhong and Lu, Feng and Wu, Qiaozhen and Liang, Weidong and Zhong, Maolin and Li, Shihong},
  title = {Beyond Inhibition: Rebalancing the Hsp90 Chaperone Network as a Therapeutic Strategy for Alzheimer’s Disease},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--15},
  doi = {10.2147/dddt.s602287}
}
Kostenlos starten →